Burkitt"s lymphoma Doctors in test — Page 2

Dr. Dror Levin specializes in pediatric hematology oncology, focusing on Burkitt's lymphoma at Sourasky Medical Center in Tel Aviv.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology Oncology (ISPHO)
• Studied bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Dr. Fredi Aviv has over 34 years of experience of experience treating blood cancers at Tel Aviv's leading Sourasky Medical Center.

• 34 years of experience dedicated to oncohematology
• Specializes in aggressive blood cancers
• Practices at the renowned Sourasky Medical Center
• Expertise in the latest medical and biological therapies

Pioneering hematologist specializing in Burkitt's lymphoma at Intrarat Hospital – trained at Thammasat University, a leading center for hematology in Thailand.

• Board-certified in hematology with focus on lymphoma cases
• Developed clinical risk prediction model for cancer-associated complications
• Former instructor for nursing students at multiple hospitals
• Active participant in Thailand's hematology academic community

Dr. Ayhan Gulsan specializes in Burkitt's lymphoma with advanced training in stem cell transplantation at Duke University and Fred Hutchinson Cancer Research Center.

• Over 25 years of experience of experience in hematology and stem cell transplantation
• Founder and manager of Gazi University's Adult Stem Cell Transplant Unit
• Member of the Turkish Hematology Association
• Published numerous research papers on hematologic malignancies and transplantation outcomes

A leading hematology expert recognized by the American Society of Hematology, Dr. Yair treats patients at Tel Aviv's Sourasky Medical Center.

• Specialized residency in hematology at Tel Aviv Medical Center
• Winner of multiple research grants and awards for clinical excellence
• Active member of both the Israeli and American Hematology Associations
• Focus on leukemia research, including lymphocytic forms

Prof. Wolfgang Köstler is a distinguished Austrian oncologist specializing in targeted cancer therapies, with over two decades of experience.

• Expert in breast cancer and gynecologic malignancies
• Developed personalized treatment strategies using advanced biomarkers
• Associate Professor at the Medical University of Vienna
• Published extensively in leading international oncology journals

Dr. Fox specializes in Burkitt's lymphoma treatment, blending innovative therapies with extensive research on haemato-oncological diseases at Medical Center in Solingen.

• Chief Physician at the Clinic for Haematology, Oncology and Palliative Care
• Expert in chemotherapy, immunotherapy, and targeted therapies
• Active member of the German Society of Oncology and Haemato-oncology
• Published research contributing to advancements in cancer treatment

Professor Drach specializes in oncology with a focus on Burkitt's lymphoma, offering expert consultations at Confraternitaet Private Hospital.

• Head physician at University Hospital of Internal Medicine I in Vienna
• Director of the Multiple Myeloma and Malignant Lymphoma program
• Member of the Board of Directors of the Austrian Society of Hematology and Oncology
• Published over 120 scientific papers

Specialized in Medical Oncology at Akdeniz University – Dr. Alemdar focuses on Burkitt's lymphoma and other hematological cancers.

• Graduated from Kocaeli University Faculty of Medicine in 2006
• Completed specialization in Medical Oncology in 2018
• Worked at Akdeniz University Hospital for several years
• Currently practices at Medical Park Antalya Hospital Complex

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Aydogdu has made significant contributions through presentations and discussions on early detection of cancer in children at Liv Bona Dea Hospital Baku.

• Specializes in early detection of pediatric cancers
• Engages in professional discussions advancing pediatric oncology
• Works at Liv Bona Dea Hospital Baku

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.